SCHEMBL4199276

SCHEMBL4199276

CCC(O)NCCNC(O)CC

nearest known ligand 0.46

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.46
CNR1 P21554 1/20 0.46
ADRA1A P35348 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
KDM4E B2RXH2 1/20 0.46
ABCC3 O15438 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
TSHR P16473 4/20 0.39
USP2 O75604 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28894825 0.89
SCHEMBL4209196 0.88 LMNA (0.36) LMNACNR1ADRA1ATDP1KDM4E
SCHEMBL133775 0.88
SCHEMBL5790232 0.88 ALDH1A1 (0.36) LMNACNR1ADRA1ATDP1KDM4E
SCHEMBL133787 0.85
SCHEMBL25800877 0.85
SCHEMBL4205138 0.85 ALDH1A1 (0.39) LMNACNR1ADRA1ATDP1KDM4E
SCHEMBL4201284 0.85 ALDH1A1 (0.39) LMNACNR1ADRA1ATDP1KDM4E
SCHEMBL337639 0.85
SCHEMBL5531400 0.83

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1828354-B1 HYDROCARBYL SUCCINIC ACID AND HYDROCARBYLSUCCINIC ACID DERIVATIVES AS FRICTION MODIFIERS BASF SE (DE) 2017-09-06 EP disclosed
US-8119840-B2 Ethambutol based nitric oxide donors THE UNIVERSITY OF AKRON (US) 2012-02-21 US disclosed
US-8119840-B2 Ethambutol based nitric oxide donors THE UNIVERSITY OF AKRON (US) 2012-02-21 US disclosed
US-20090235576-A1 HYDROCARBYL SUCCINIC ACID AND HYDROCARBYLSUCCINIC ACID DERIVATIVES AS FRICTION MODIFIERS BASF AKTIENGESELLSCHAFT (DE) 2009-09-24 US disclosed
US-20090069449-A1 ETHAMBUTOL BASED NITRIC OXIDE DONORS THE UNIVERSITY OF AKRON (US) 2009-03-12 US disclosed
US-20090069449-A1 ETHAMBUTOL BASED NITRIC OXIDE DONORS THE UNIVERSITY OF AKRON (US) 2009-03-12 US disclosed
EP-1828354-A1 HYDROCARBYL SUCCINIC ACID AND HYDROCARBYLSUCCINIC ACID DERIVATIVES AS FRICTION MODIFIERS BASF AKTIENGESELLSCHAFT (DE) 2007-09-05 EP disclosed
WO-2006063770-A1 HYDROCARBYL SUCCINIC ACID AND HYDROCARBYLSUCCINIC ACID DERIVATIVES AS FRICTION MODIFIERS BASF AKTIENGESELLSCHAFT (DE) 2006-06-22 WO disclosed
EP-1669433-A1 Hydrocarbyl succinic acid and hydrocarbylsuccinic acid derivatives as friction modifiers BASF AKTIENGESELLSCHAFT (DE) 2006-06-14 EP disclosed
EP-0726919-B1 AQUEOUS PAINTS AND THEIR USE TO PRODUCE FILLER LAYERS IN AUTOMOBILE PAINTING BASF COATINGS AG (DE) 2001-06-06 EP disclosed
EP-0802244-A1 Method for improving the brightness and levelling of lacquers BASF Lacke + Farben AG (DE) 1997-10-22 EP disclosed
EP-0726919-A1 AQUEOUS PAINTS AND THEIR USE TO PRODUCE FILLER LAYERS IN AUTOMOBILE PAINTING BASF Lacke + Farben AG (DE) 1996-08-21 EP disclosed
EP-0459125-B1 Process for the preparation of diols containing perfluoroalkylrests and polyurethanes. PFERSEE CHEM FAB (DE) 1995-07-12 EP disclosed
WO-1995012626-A1 AQUEOUS PAINTS AND THEIR USE TO PRODUCE FILLER LAYERS IN AUTOMOBILE PAINTING BASF LACKE + FARBEN AG (DE) 1995-05-11 WO disclosed
EP-0621881-A1 PROCESS FOR INCREASING STABILITY OF POLY(ESTERAMIDES). MINNESOTA MINING & MFG (US) 1994-11-02 EP disclosed
WO-1993015130-A2 PROCESS FOR INCREASING STABILITY OF POLY(ESTERAMIDES) MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1993-08-05 WO disclosed
EP-0467083-A2 Perfluoroaliphatic group-containing copolymers with urethane and siloxane units Pfersee Chemie GmbH (DE) 1992-01-22 EP disclosed
EP-0459125-A1 Process for the preparation of diols containing perfluoroalkylrests and polyurethanes. Pfersee Chemie GmbH (DE) 1991-12-04 EP disclosed
US-3970601-A COATINGS BAYER AKTIENGESELLSCHAFT (DT) 1976-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069449-A1 ETHAMBUTOL BASED NITRIC OXIDE DONORS NOS2, NOS1, NOS3 LMNA 4788/4885CNR1 1050/4885ADRA1A 1873/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.